Fecal calprotectin concentration is increased in children with celiac disease: Relation with histopathological findings

Turkish Journal of Gastroenterology

Volumn 23, Issue 5, 2012, Pages 503-508

  Balamtekin, Necati ^a   Baysoy, Gökhan ^b   Uslu, Nuray ^b   Orhan, Diclehan ^b   Akçören, Zuhal ^b   Özen, Hasan ^b   Gürakan, Figen ^b   Saltik Temizel, Inci Nur ^b   Yüce, Aysel ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Celiac disease; Children; Fecal calprotectin

Indexed keywords

CALGRANULIN; ENDOMYSIUM ANTIBODY;

ARTICLE; CELIAC DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FECES LEVEL; FEMALE; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PRESCHOOL CHILD; SCHOOL CHILD; SMALL INTESTINE MUCOSA; STATISTICAL SIGNIFICANCE;

BIOPSY; CELIAC DISEASE; CHILD; DIAGNOSIS, DIFFERENTIAL; FECES; FEMALE; HUMANS; INTESTINAL MUCOSA; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; RETROSPECTIVE STUDIES;

EID: 84871108695     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2012.0366     Document Type: Article

References (27)

1. Sutherland AD, Gearry RB, Frizelle FA. Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum 2008; 51: 1283-91.
2. Damms A, Bischoff SC. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. Int J Colorectal Dis 2008; 23: 985-92.
3. Jacob M, Foster R, Sigthorsson G, et al. Role of bile in pathogenesis of indomethacin-induced enteropathy. Arch Toxicol 2007; 8: 291-8. (Pubitemid 46434776)
4. Yagmur E, Schnyder B, Scholten D, et al. Elevated concentrations of fecal calprotectin in patients with liver cirrhosis. Dtsch Med Wochenschr 2006; 131: 1930-4. (Pubitemid 44543506)
5. Montalto M, Santoro L, Curigliano V, et al. Fecal calprotectin concentrations in untreated coeliac patients. Scand J Gastroenterol 2007; 42: 957-61. (Pubitemid 47037122)
6. Canani RB, Rapacciuolo L, Romano MT, et al. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 2004; 36: 467-70. (Pubitemid 41115450)
7. Ertekin V, Selimoglu MA, Turgut A, Bakan N. Fecal calprotectin concentrations in children with celiac disease. J Clin Gastroenterol 2010; 44: 544-6.
8. Report of the Working Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990; 65: 909-11.
9. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-94. (Pubitemid 30433773)
10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
11. Aadland E, Fagerhol MK. Fecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002; 14: 823-5. (Pubitemid 34913578)
12. Canani RB, Terrin G, Rapacciuolo L, et al. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis 2008; 40: 547-53.
13. Quail MA, Russell RK, Van Limbergen JE, et al. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 756-9.
14. Ashorn S, Honkanen T, Kolho KL, et al. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 199-205.
15. Gisbert JP, Bermejo F, Perez-Calle JL, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009; 15: 1190-8.
16. Schoepfer AM, Beglinger C, Straumann A, Trummler M, Renzulli P, Seibold F. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis 2009; 15: 1851-8.
17. Shastari YM, Bergis D, Povse N, et al. Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea. Am J Med 2008; 121: 1099-106.
18. Schoepfer AM, Trummler M, Seeholzer P, et al. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis 2008; 14: 32-9. (Pubitemid 351196866)
19. Silberer H, Küppers B, Mickisch O, et al. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab 2005; 51: 117-26. (Pubitemid 40520584)
20. Schoepfer AM, Beglinger C, Straumann A, et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 2010; 105: 162-9.
21. Li XG, Lu YM, Gu F, Yang XL. Fecal calprotectin in differential diagnosis of irritable bowel syndrome. Beijing Da Xue Xue Bao 2006; 38: 310-3.
22. Bonnin TA, Vila VM, Rosell CA. Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease. Rev Esp Enferm Dig 2007; 99: 689-93.
23. Bremner A, Roked S, Robinson R, et al. Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatr 2005; 94: 1855-8. (Pubitemid 43155608)
24. Lancaster-Smith, Packer S, Kumar PJ, Harries JT. Cellular infiltrate of the jejunum after re-introduction of dietary gluten in children with treated coeliac disease. J Clin Path 1976; 29: 587-91.
25. Dhesi I, Marsh MN, Kelly C, Crowe P. Morphometric analysis of small intestinal mucosa. II. Determination of lamina propria volumes; plasma cell and neutrophil populations within control and coeliac disease mucosae. Virchows Arch A Pathol Anat Histopathol 1984; 403: 173-80. (Pubitemid 14139751)
26. Hallgreen R, Colombel JF, Dahl R, et al. Neutrophil and eosinophil involvement of small bowel in patients with celiac disease and Crohn's disease: studies on secretion rate and immunohistochemical localization of granulocyte granule constituents. Am J Med 1989; 86: 56-64. (Pubitemid 19039538)
27. Kristjánsson G, Högman M, Venge P, Höllgren R. Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn. Gut 2005; 54: 769-74. (Pubitemid 40732091)